BioVie Inc BIVI:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/28/24 EDT
0.53UNCH (UNCH)
Volume
6,312
Close
0.5286UNCH (UNCH)
Volume
749,584
52 week range
0.48 - 8.97
Loading...
  • Open0.5336
  • Day High0.5448
  • Day Low0.51
  • Prev Close0.5336
  • 52 Week High8.97
  • 52 Week High Date03/28/23
  • 52 Week Low0.48
  • 52 Week Low Date03/27/24

Key Stats

  • Market Cap29.033M
  • Shares Out54.92M
  • 10 Day Average Volume1.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-58.05

KEY STATS

  • Open0.5336
  • Day High0.5448
  • Day Low0.51
  • Prev Close0.5336
  • 52 Week High8.97
  • 52 Week High Date03/28/23
  • 52 Week Low0.48
  • 52 Week Low Date03/27/24
  • Market Cap29.033M
  • Shares Out54.92M
  • 10 Day Average Volume1.17M
  • Dividend-
  • Dividend Yield-
  • Beta1.26
  • YTD % Change-58.05

RATIOS/PROFITABILITY

  • EPS (TTM)-1.19
  • P/E (TTM)-0.44
  • Fwd P/E (NTM)-0.42
  • EBITDA (TTM)-44.179M
  • ROE (TTM)-257.84%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)136.10%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioVie Inc

 

Profile

MORE
BioVie Inc. is a clinical-stage company engaged in developing drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease. In neurodegenerative disease, the Company’s drug candidate NE3107 inhibits inflammatory activation of extracellular single-regulated kinase (ERK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) that leads to neuroinflammation and insulin resistance, but not their homeostatic...
James Lang
Independent Chairman of the Board
Cuong Do
President, Chief Executive Officer, Director
Joanne Kim CPA
Chief Financial Officer, Corporate Secretary
Address
680 W NYE LANE, SUITE 201
Carson City, NV
89703
United States

Top Peers

SYMBOLLASTCHG%CHG
NGNE
Neurogene Inc
50.90UNCHUNCH
ACXP
Acurx Pharmaceuticals Inc
2.45UNCHUNCH
ALRN
Aileron Therapeutics Inc
6.50UNCHUNCH
INKT
Mink Therapeutics Inc
0.9083UNCHUNCH
SNSE
Sensei Biotherapeutics Inc
1.05UNCHUNCH